Skip to main content

Will New Trademark Regime Raise the Bar?

July 4, 2016

In the August/September issue of the World Trademark Review Susan Keri and Meghan Dillon discuss the impact Canada’s new Trademarks Act will have on pharmaceutical companies and their trademark strategies.

This article first appeared in World Trademark Review issue 62, published by Globe Business Media Group - IP Division.
To view the issue in full, please go to WorldTrademarkReview.com.


To read the article, download the PDF below.

Content shared on Bereskin & Parr’s website is for information purposes only. It should not be taken as legal or professional advice. To obtain such advice, please contact a Bereskin & Parr LLP professional. We will be pleased to help you.

Author(s):

Susan Keri Susan Keri
B.A., LL.B.
Partner
416.957.1165  email Susan Keri
Meghan Dillon Meghan Dillon
B.Sc. (Psych.), LL.B.
Partner
416.957.1160  email Meghan Dillon